Atrazine is a competitive inhibitor of phosphodiesterase but does not affect the estrogen receptor
- 1 December 2004
- journal article
- Published by Elsevier in Toxicology Letters
- Vol. 154 (1-2) , 61-68
- https://doi.org/10.1016/j.toxlet.2004.07.005
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Male reproductive effects of octylphenol and estradiol in Fischer and Wistar ratsReproductive Toxicology, 2003
- Cyclic Nucleotide Phosphodiesterase Activity, Expression, and Targeting in Cells of the Cardiovascular SystemMolecular Pharmacology, 2003
- cAMP effector mechanisms. Novel twists for an ‘old’ signaling systemFEBS Letters, 2003
- Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in miceHuman Molecular Genetics, 2003
- CYCLIC AMP SIGNALING AND GENE REGULATIONAnnual Review of Nutrition, 1998
- Studies of Gonadotropin-Releasing Hormone (GnRH) Action Using GnRH Receptor-Expressing Pituitary Cell LinesEndocrine Reviews, 1997
- Effect of atrazine on ovarian function in the ratReproductive Toxicology, 1996
- Down-regulation of the gonadotropin-releasing hormone receptor messenger ribonucleic acid by activation of adenylyl cyclase in alpha T3-1 pituitary gonadotrope cellsEndocrinology, 1995
- Possible antiestrogenic properties of chloro‐s‐triazines in rat uterusJournal of Toxicology and Environmental Health, 1994
- Differences in cAMP Levels in the Gingival Fluid of Diabetics and NondiabeticsThe Journal of Periodontology, 1975